Research on the evolution and diffusion mechanism of drug negotiation policy in China*

Corresponding author: LYU Lan-ting, lanting.lyu@ruc.edu.cn

DOI: 10.12201/bmr.202210.00019

•  

  Abstract: The national drug negotiation mechanism is an important institutional arrangement to promote the high-quality development of Chinas medical security reform. Based on the policy diffusion theory, this paper discussed the diffusion process of Chinas negotiated drug policy from 2009 to 2021 from five dimensions of time, space, subject, content and path. The results showed that although the diffusion of negotiation drug policy in China was unique, it was basically in accord with the characteristic path of Chinas medical reform. In the time dimension, the diffusion curve presents an approximate S-shaped distribution; In spatial dimension, the promotion of State Administration can change the effect of hierarchical and proximity effect; In the subject dimension, there are obvious stages in the cooperation between the subjects; In terms of content, the policies pay more attention to innovation in the later stage and the focus of them gradually shifts from service innovation to process innovation and auxiliary innovation; In the path dimension, taking special drug management and two-channel mechanism as examples, the diffusion modes are of local government exploration, central government vertical influence and promotion after policy absorption. Comprehensively understand the regular pattern of drug negotiation policy diffusion, so as to provide reference for promoting the process of public policy diffusion in the field of health in China and ensuring the quality of policy implementation.

  Key words: drug negotiation; policy diffusion; policy evolution; local government

  Submit time: 25 October 2022

  Copyright: The copyright holder for this preprint is the author/funder, who has granted biomedRxiv a license to display the preprint in perpetuity.
• html

• 图表

• Li Xianzhe, Ma Jiyan, Cheng Haozhe, Yang Mingfang, Huang Yangmu. Policy Diffusion in China’s Pharmaceutical R&D. 2021. doi: 10.12201/bmr.202103.00007

  GONG XIUQUAN, Bai Haining. Ｒesearch on the policy diffusion of hospice care in Shanghai. 2022. doi: 10.12201/bmr.202209.00001

  PEI Chen-yang, HU Lin-lin, LIU Yuan-li. Policy Evolution and Recommendations of Elderly Health Care Service in China. 2020. doi: 10.12201/bmr.202007.00026

  duqian, QIU Yu-lin. Innovation and Diffusion of Grassroots Government：case study of Urban And Rural Residents Medical Insurance. 2021. doi: 10.12201/bmr.202007.00027

  songjia, fanchengxin, wangwanchen, aixufeng, liuxinlu, licuiyu, zhangyujie, liqiusha, wanganqi, fengzhiqiang, yinwenqiang, madongping. Study on Chinas centralized quantity purchasing policy for drugs from the perspective of stakeholders - a textual analysis based on policy tools. 2022. doi: 10.12201/bmr.202203.00006

  Li Hong-yu, Sun Qiang. Analysis of the impact of the Two Ballot System policy on drug supply in Shandong province. 2021. doi: 10.12201/bmr.202011.00015

  wangyuanru, huzixin, xiejinping, shaorong. Analysis of the European Unions Orphan Drug Designation Policy and Its Enlightenment to China. 2022. doi: 10.12201/bmr.202207.00031

  Li Xinyu, Shao Rong, Bai Mingyu, Li Dashuang, Yan Jianzhou. Text Quantitative Analysis of Pediatric Drug Security policy-- A two-dimensional framework based on policy tools and policy goals. 2022. doi: 10.12201/bmr.202209.00016

  JiangMingzhu, Ying Xiaohua. Quantitative research of vaccine management policy in China - Text analysis based on policy instruments, policy subjects and policy points. 2022. doi: 10.12201/bmr.202212.00005

  SHI Zhen-yu, JIA Yan-bing, XU Jin, YUAN Bei-bei, MENG Qing-yue, HE Ping. Policy translation of health policy and systems research in China. 2020. doi: 10.12201/bmr.202006.00011

• ID	Submit time	Number	Download
  1	2022-07-12	bmr.202210.00019V1	Download

• Public  Anonymous  To author only Submit Comments